This webinar occurred on June 7, 2023 and continuing education expires on June 7, 2024
About the Webinar
The Washington Department of Health (DOH) hosted a webinar on Wednesday, June 7, 2023. Department of Health staff discussed school and child care immunization requirements for the upcoming school year. This webinar is intended for healthcare providers, health educators, and anyone who may interested in learning detailed information on immunization requirements. Continuing education is available for physicians, nurses, medical assistants, and pharmacists/pharmacy techs.
- Identify updated school and child care immunization requirements, including changes to DTP, Tdap, polio, and requirements for 4 year old students
- Describe how to complete the Certificate of Immunization Status and forms that healthcare providers can give to families
- Discuss school and child care exemption requirements in Washington State and how healthcare providers should complete the Certificate of Exemption
- Identify clinic-based and external resources for vaccinating patients
Healthcare providers, pharmacists/pharmacy technicians, health educators, and anyone interested in learning more details about school and child care immunization requirements. The webinar on March 30 was geared towards school and child care staff while this webinar is geared towards healthcare providers.
Presenters from the Washington Department of Health
Katherine Graff, BSN, RN
School and Child Care Immunization Nurse Consultant
Phillip Wiltzius, MS, CHES
School and Child Care Health Educator
- There is no charge for continuing education credit.
- Continuing education (CE) is available for physicians, nurses, medical assistants, and pharmacists/pharmacy techs for attending the live webinar OR watching the recording.
- Even if you attend the live webinar or watch the recording as a group, everyone MUST register for the webinar and complete the evaluation as an individual prior to receiving CE.
- More information about the process to receive CE will be posted after the webinar.
Continuing Nursing Education
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation. 1.0 contact hours will be awarded for successful completion of this activity.
Continuing Education for Medical Assistants
1.0 administrative continuing education unit was approved by the American Association of Medical Assistants (AAMA). Granting approval in no way constitutes endorsement by the AAMA of the program content or the program’s sponsor.
Continuing Education for Pharmacists and Pharmacy Technicians
This knowledge-based activity was approved by the Washington State Pharmacy Association for 1.0 contact hours.
Universal Activity Number (UAN):
The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education.
Continuing Education for Health Educators
This event has been approved by the Washington State Department of Health (DOH) to award up to 1.0 Category I CHES/MCHES continuing education contact hours. DOH is an approved multiple event provider by the National Commission for Health Education Credentialing, Inc. (NCHEC). Provider Number 1147801.
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Federation of State Medical Boards, the Washington Medical Commission and the Washington State Department of Health. The Federation of State Medical Boards is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Federation of State Medical Boards designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Pam Kohlmeier, MD, JD, FACEP
Washington Medical Commission
As an organization accredited by the ACCME, the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. All faculty, planners, and others in a position to control continuing medical education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Faculty (authors, presenters, speakers and planners) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.
Faculty members are asked to disclose all financial relationships they have had in the past 24 months with ineligible companies regardless of the potential relevance of each relationship to the education and of the amount. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. Planners, speakers, faculty members, and others in control of content have no relevant financial relationships with ineligible companies.
Disclosure of Unlabeled Uses
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physicians’ Desk Reference.
No speakers or persons in control of content reported intent to reference unlabeled/unapproved uses of drugs or products.
No commercial support was used for this educational activity.